Querido JS, Kennedy PM, Sheel AW. Hyperoxia attenuates muscle sympathetic nerve activity following isocapnic hypoxia in humans. J Appl Physiol 108: 906 -912, 2010. First published February 11, 2010 doi:10.1152/japplphysiol.01228.2009.-Hypoxia may sensitize the carotid chemoreceptors, resulting in a sustained elevation of muscle sympathetic nerve activity (MSNA) that outlasts the hypoxic stimulus. To test this hypothesis, we determined the effect of carotid body inhibition on the sustained elevation of MSNA following isocapnic hypoxia in humans. Seven healthy subjects (5 male, 2 female) breathed 100% O2 (hyperoxia) for 1 min before (2 interventions) and after (2-3 interventions) 20 min of isocapnic hypoxia (80% arterial oxyhemoglobin saturation). MSNA was continuously recorded from the common peroneal nerve with microneurography. There was no effect of hyperoxia on MSNA before exposure to isocapnic hypoxia. During the isocapnic hypoxia exposure, there was an increase in minute ventilation and heart rate that subsided once hypoxia was terminated. In contrast, there was an increase in MSNA burst frequency that persisted for ϳ25 min after cessation of the stimulus. Hyperoxia resulted in a transient reduction in MSNA burst frequency of 28% (P Ͻ 0.05), 15% (P Ͻ 0.05), and 9% (P Ͼ 0.05) in the three posthypoxia interventions, respectively. Our results suggest that input from the carotid chemoreceptors is obligatory for the sustained elevation of MSNA initiated by chemoreflex stimulation. We attribute the decrease in MSNA to a transient hyperoxia-induced attenuation of carotid chemoreceptor sensitivity. chemoreflex; sympathoexcitation; carotid chemoreceptor inhibition ACUTE EXPOSURE TO HYPOXIA elicits abrupt increases in respiratory and circulatory measures. In particular, large increases in muscle sympathetic nerve activity (MSNA) are observed in hypoxia and are dose-dependent (24). The proposed mechanism is a hypoxiamediated increase in afferent signals from the O 2 -sensitive carotid chemoreceptors (CC), which in turn increases ventilatory drive and vasomotor outflow (10). Consequently, the CC play an obligatory role in mediating the cardiorespiratory and sympathetic responses to acute hypoxia (8, 20, 38) .
tion of the CC with hypercapnia does not result in long-lasting sympathoexcitation (44) . 2) Healthy human and pathological models of intermittent hypoxia modulate CC activity, which results in heightened MSNA in normoxia and hypoxia (16, 21) .
3) CC sensitivity may be enhanced after hypoxic stimulation, as demonstrated by a trend for an increase in the magnitude of the ventilatory and sympathetic outflow responses to acute isocapnic hypoxia (24) . Taken together, these findings suggest that sustained sympathoexcitation following hypoxia is dependent on elevated CC activity; however, no study has systematically investigated this possibility. Therefore, the purpose of the present investigation was to determine the contribution of the chemoreflex to persistent sympathoexcitation following isocapnic hypoxia. Accordingly, we recorded MSNA in healthy humans during brief bouts of hyperoxia before and after 20 min of sustained isocapnic hypoxia. We hypothesized that transient CC inhibition with hyperoxia would lower sympathetic activity following acute isocapnic hypoxia.
MATERIALS AND METHODS
Subject characteristics. Seven healthy subjects (30 Ϯ 3 yr; 2 female) of normal height (176 Ϯ 3 cm) and weight (73 Ϯ 5 kg) who were free from cardiovascular, pulmonary, and neurological diseases participated in the study. A history of smoking, hypertension, sleep apnea, altitude exposure within 6 mo before testing, or participation in breath-hold activities excluded participation. On an initial visit, written informed consent was obtained and subjects underwent a familiarization session, where all experimental procedures, excluding microneurography, were performed. All experimental procedures and protocols were approved by the Clinical Research Ethics Board at the University of British Columbia, which conforms to the Declaration of Helsinki.
Experimental protocol. Subjects remained recumbent throughout testing while ventilatory, cardiovascular, and MSNA measures were continuously recorded. After instrumentation, the experimental session began with Ն15 min of eupnea to obtain resting data. As previously described (21) , exposure to isocapnic hypoxia was then accomplished by titration of 100% N2 into the inspired circuit to maintain oxyhemoglobin saturation (SpO2) at 80% for 20 min. Isocapnia was maintained by the manual addition of 100% CO2 to the inspirate as needed. This isocapnic hypoxia protocol was selected to allow direct comparison with other previously published data that demonstrated persistent sympathoexcitation following hypoxia exposure (21, 44) . After isocapnic hypoxia, we continued to record ventilatory, cardiovascular, and sympathetic measures while subjects breathed normoxic air.
The contribution of the CC to MSNA was investigated by exposure to hyperoxia for 1 min before (2 interventions) and after (2-3 interventions) the 20-min isocapnic hypoxia exposure. After termination of the isocapnic hypoxia exposure, subjects breathed room air for 5 min before the first hyperoxia intervention. Subsequent hyperoxia interventions were separated by 5 min to allow normalization of inspired O2 levels. Hyperoxia was accomplished by switching the inspired circuit to a reservoir containing 100% O2. Hyperoxia was selected because it has been shown to transiently inhibit the CC (14, 28, 35, 42) .
Cardiorespiratory measures.
A face mask was connected to a calibrated pneumotachograph (model 3813, Hans Rudolph, Kansas City, MO) for determination of inspiratory flow. Tidal volume (VT) and breathing frequency (f b) were determined from the flow signal, and minute ventilation (V I) was calculated from the product of fb and VT. O2 and CO2 were measured at the mouth with calibrated gas analyzers (models S-3A/I and CD-A, Applied Electrochemistry, Pittsburgh, PA). SpO 2 was measured with a finger pulse oximeter (model 3740, Ohmeda, Louisville, CO). A single-lead electrocardiogram was continuously recorded to determine heart rate (HR). Beat-by-beat blood pressure was monitored at the finger with photoplethysmography (Finometer, Finapres Medical System, Arnhem, The Netherlands).
MSNA. Direct postganglionic MSNA was recorded from the peroneal nerve with use of the microneurography technique (21, 39) . Briefly, a recording microelectrode was placed into the common peroneal nerve for recording of electrical activity. After localization of the common peroneal nerve via surface and subcutaneous stimulation, a recording tungsten microelectrode (10-m tip diameter, 35 mm; Frederick Haer, Bowdoinham, ME) was advanced posterior to the fibular head until sufficient electrical activity was obtained. Nerve electrical signals were rectified and amplified (total gain 50,000, custom-built microneurography preamplifier and amplifier; Yale University, New Haven, CT), band-pass filtered (300 -5,000 Hz), and integrated (100-ms time constant; integrator model B937C, Bioengineering, University of Iowa, Iowa City, IA). Correct recording placement was confirmed by 1) pulse synchronous nerve electrical activity, 2) activation with a breath-hold or during phase II of a Valsalva maneuver, 3) activity in response to tapping or stretching of the muscle, and 4) no activation upon gentle stroking of the skin or startle stimuli. Once a sufficient recording (Ͼ3:1 signal-to-noise ratio) was obtained, the subjects were instructed to remain relaxed and still to avoid displacement of the recording microelectrode. In addition, the leg was placed in a custom-fit brace to ensure leg immobility. The integrated neurogram was time-shifted to align each sympathetic burst to a corresponding R wave from the electrocardiogram and high-passfiltered to set the noise threshold to zero. After burst identification in the integrated neurogram from computer software (Chart version 7.0.1, ADInstruments), bursts were confirmed by visual inspection. For quantification, MSNA was expressed as burst frequency (bursts/ min), burst incidence (bursts/100 heartbeats), and total MSNA (MSNA frequency ϫ MSNA amplitude, in arbitrary units).
Data and statistical analyses. All data were acquired using an analog-to-digital converter and sampled at 1 kHz. Data were stored on a personal computer for subsequent offline analysis. For investigation of the effect of hypoxia, measured variables were averaged over 5-min segments during baseline, hypoxia, and recovery. Differences between these conditions were determined with repeated-measures ANOVA. For characterization of MSNA responses to hyperoxia following hypoxia, 1-min steady-state values were compared using repeated-measures ANOVA. In the case of a significant F ratio, differences were further investigated with Tukey's post hoc analysis. A paired t-test was used to compare the nadir 1-min MSNA burst frequency during hyperoxia interventions with the 1-min steady-state MSNA burst frequency before hyperoxia. There were no differences in MSNA responses to hyperoxia before hypoxia; therefore, the mean of the two trials was used. The level of significance was set at P Ͻ 0.05 for all statistical calculations. Group data are presented as means Ϯ SE. Figure 1 shows an MSNA trace and corresponding measurements for one subject. Group mean data for the effects of isocapnic hypoxia on cardiorespiratory and MSNA measurements are shown in Table 1 . HR increased during hypoxia but returned to baseline levels once room air breathing was resumed. There was no consistent effect of hypoxia on mean arterial pressure (MAP). Exposure to hypoxia resulted in significant increases in V I and VT, but both returned to baseline upon termination of the hypoxia exposure. There was a small (1-mmHg) decrease in end-tidal PCO 2 during the first 5 min of hypoxia, but overall isocapnia was well maintained throughout the hypoxia exposure. A significant decrease in SpO 2 was achieved within the first 5 min of hypoxia, and the target SpO 2 (80%) was maintained for the remainder of hypoxia (Fig. 2) . MSNA burst frequency and total MSNA increased during hypoxia relative to baseline and remained elevated into normoxic recovery.
RESULTS

Effects of isocapnic hypoxia.
Effects of hyperoxia. Hyperoxia interventions performed at baseline resulted in a small increase in f b and SpO 2 that reached statistical significance (Table 2 ). In contrast, there was no effect of hyperoxia on other cardiorespiratory measures. Similarly, MSNA measures were not affected by hyperoxia (P Ͼ 0.05).
After hypoxia, there was no effect of hyperoxia on cardiorespiratory measures. As a group, MSNA burst frequency decreased during hyperoxia interventions 1 and 2 after hypoxia (Fig. 3) . The nadir MSNA burst frequency occurred in the 1 min following hyperoxia; however, the decrease was transient. That is, MSNA burst frequency returned to an elevated level relative to baseline within 5 min after hyperoxia. The nadir reduction in MSNA burst frequency was significantly greater in intervention 1 (Ϫ28 Ϯ 3%) than in interventions 2 and 3 (Ϫ15 Ϯ 4% and Ϫ9 Ϯ 6%, respectively; Fig. 3 ). A total of 18 hyperoxia trials were completed after hypoxia, and a decrease in MSNA burst frequency was observed in 16 of these trials (Fig. 4) . The two hyperoxia trials where MSNA burst frequency did not decrease were observed in the same subject (in interventions 2 and 3). In addition, the MSNA burst frequency response to hyperoxia was significantly related to the normoxic MSNA levels in hyperoxia interventions 1 and 2 (r 2 ϭ 0.77 and 0.89, respectively). There was no effect of hyperoxia on MSNA burst incidence or total MSNA.
DISCUSSION
Main findings. We measured the cardiorespiratory and MSNA responses to 20 min of isocapnic hypoxia and CC inhibition with hyperoxia. We (21) and others (44) previously showed that acute exposure to hypoxia results in increases in MSNA that persist after termination of the hypoxia exposure. In the present study, we showed a transient decrease in the sympathoexcitation from isocapnic hypoxia by inhibition of the CC with hyperoxia. These results support the concept of long-lasting facilitation of sympathetic outflow, which is dependent on input from the CC.
Sympathoexcitation with isocapnic hypoxia. In the present study, we showed that hypoxia resulted in sympathoexcitation, which is thought to be initiated by the carotid chemoreflex (10) . In the present study, the chemoreflex was activated by an increase in the activity of hypoxia-mediated afferents originating from the CC. We subsequently observed an increase in sympathetic vasomotor outflow. This response requires CC stimulation, since sympathoexcitation with hypoxia is abolished after denervation of the carotid sinus nerve in rats (19) . Although data from rodents showed that severe hypoxia directly stimulates central neurons and increases sympathetic outflow (36) , this response requires a greater level of hypoxia (10% to 5% O 2 ) than that used in the present study (ϳ12% O 2 ). Therefore, it is unlikely that direct stimulation of brain stem neurons contributed to the sympathoexcitation observed during our moderate hypoxia protocol.
We observed a small reduction in MSNA burst frequency at 15 and 20 min of hypoxia (Table 1) . However, MSNA burst frequency remained significantly elevated from baseline, and there was no significant difference in MSNA burst frequency between 5, 10, 15, and 20 min of hypoxia. Although we attributed the hypoxia-induced sympathoexcitation to the CC, V I was not reduced at 15 and 20 min of hypoxia, which suggests that the effect was not due to decreased CC activity. The physiological mechanism responsible for the small reduction in MSNA burst frequency in unclear.
Persistent sympathoexcitation following isocapnic hypoxia and inhibition with hyperoxia. We found that hypoxia-mediated sympathoexcitation outlasts the hypoxic stimulus. Although this finding is consistent with previous literature (21, 44) , the mechanisms underlying this response are unclear. We consider it unlikely that a persistent chemical stimulus was responsible for the sustained sympathoexcitation, because end-tidal gases and SpO 2 quickly returned to baseline values. A persistent change in the intracellular milieu of the CC remains possible; however, this would be expected to be accompanied by a sustained increase in V I, which was not demonstrated in our data.
We considered the possibility that the persistent sympathoexcitation was an effect of long-term potentiation of postganglionic nerves (23) . Although our data cannot directly address this issue, it is doubtful that long-term potentiation explains our results, given that exposure to stimuli other than hypoxia does not produce sympathoexcitation that outlasts the stimulus. For example, Xie and colleagues (44) demonstrated a sustained elevation in sympathetic outflow following isocapnic hypoxia. However, there was no persistent sympathoexcitation following normoxic hypercapnia, even though the magnitude of the MSNA response during the exposure was matched between trials.
The role of the CC in the sympathetic component of the chemoreflex has been well described elsewhere (10) . However, the role of the CC in sustained sympathoexcitation following hypoxia is less clear. Data from an investigation using goats demonstrate a gradual increase in chemoafferent discharge in hypoxia (27) . This suggests that hypoxia increases hypoxic sen- sitivity of the CC. Data from humans suggest that CC sensitivity to hypoxia increases, which is demonstrated by a trend for increases in the ventilatory and sympathetic responses to hypoxia following 20 min of hypercapnic hypoxia (24) . There is also an increase in CC sensitivity following intermittent hypoxia, which is coupled with sympathoexcitation (21) . Finally, in patients with sleep apnea, high levels of MSNA throughout the day are associated with sensitized peripheral chemoreceptors, and attenuation of peripheral chemoreceptors with hyperoxia decreases MSNA in these patients (25, 26) . In the present study, hyperoxia resulted in a transient decrease in the persistent sympathoexcitation following exposure to hypoxia. We attribute this effect to a direct consequence of CC inhibition with hyperoxia.
The lines of evidence mentioned above suggest that the sustained sympathoexcitation we observed was due to continued input from sensitized CC, and inhibition of "overactive" CC afferents with hyperoxia resulted in transient attenuation of MSNA. Hypoxia-induced sympathoexcitation was especially evident in one of our subjects (Fig. 4) , which may have inflated the group average; however, statistical significance was obtained after reanalysis subsequent to removal of this subject's data. Therefore, our conclusion was not driven by data from this one subject.
Our data showed a progressive decrease in the MSNA burst frequency response to hyperoxia, which showed no significant effect of hyperoxia by intervention 3. Although an explanation for this trend is not apparent, it is important to note that successful neural recordings were not obtained during hyperoxia interventions 2 and 3 (n ϭ 6 and 5, respectively) in all subjects. One subject demonstrated slight increases in MSNA burst frequency during hyperoxia interventions 2 and 3, resulting in an "attenuated" decreased response to hyperoxia. Alternatively, the response might be due to a physiological (chemoreceptor) desensitization to hyperoxia by recurrent exposures to hyperoxia, which may be supported by the correlation between normoxic MSNA burst frequency and the MSNA response to hyperoxia in hyperoxia interventions 1 and 2. However, this is speculative, and our study cannot appropriately support these explanations.
Others considered the long-lasting sympathoexcitation to be an integrated response between the CC and rostral ventrolateral medullary (VLM) neurons. Morgan and colleagues (24) found that hypercapnic hypoxia produced sympathoexcitation that outlasted the stimulus, and hyperoxia attenuated the sympathoexcitation in three subjects. These investigators hypothesized that the persistent sympathoexcitation was due to a memory-like effect in rostral VLM neurons that required peripheral chemoreceptor input. We cannot rule out the possibility that the transient decrease in sympathetic outflow with hyperoxia we observed was due to an interplay between the CC and central integration of afferent signals. However, we used short bouts of hyperoxia, which inhibit the CC (7). It is possible that longer exposures to hyperoxia could have influenced rostral VLM neurons, although the response would most likely be excitatory (6) . Furthermore, if our transient hyperoxia protocol had a direct effect on the central medullary neurons, we would have expected to observe an effect on MSNA during baseline (prehypoxia) trials. It is also important to note that Morgan and colleagues utilized a hypercapnic hypoxia intervention, which could have had a direct stimulatory effect on central medullary chemoreceptors. This makes direct comparisons with our data difficult.
The increase in MSNA burst frequency in hypoxia was not accompanied by a change in MSNA burst incidence. Therefore, the tachycardic response to hypoxia likely explains the discrepancy between MSNA burst frequency and burst incidence in hypoxia (30, 34) . Accordingly, MSNA burst incidence was increased in normoxic recovery because of the persistent elevation of MSNA burst frequency and a decrease in HR toward baseline values. MSNA burst frequency provides a general measure of sympathetic outflow, whereas MSNA burst incidence is "gated" by the arterial baroreceptors (17) . Although speculative, this implies that there is modification of the arterial baroreflex following exposure to hypoxia, which may stem from a change in the arterial baroreflex that occurs in hypoxia (11, 15) . A more complete explanation of our MSNA burst incidence results and the relation of MSNA burst incidence to the arterial baroreflex requires further study employing an assessment of baroreflex function.
Removal of the CC attenuates sympathoexcitation with hypoxia, although it does not abolish "tonic" sympathetic outflow at rest (2) . Resting discharge of postganglionic sympathetic nerves originates from intrinsic pacemaker properties of rostral VLM neurons (10). Our results are consistent with previous studies and demonstrate no effect of CC inhibition with hyperoxia on sympathetic outflow before exposure to hypoxia (3, 24, 35) . We consider the transient hyperoxia to have a minimal effect on the CC and the rostral VLM sympathoexcitatory neurons, resulting in no change in MSNA before exposure to hypoxia. In contrast, hyperoxia before exposure to hypoxia resulted in a small, yet significant, increase in f b ; however, the magnitude of the increase was not enough to result in a change in V I. Hyperoxic hyperventilation tends to require a longer exposure to hyperoxia (6); therefore, the physiological significance of the small increase in f b from hyperoxia before exposure to hypoxia is unclear and requires further study to provide a possible explanation.
Recovery of cardiorespiratory measures following isocapnic hypoxia. If the sustained sympathoexcitation is due to an increase in CC sensitivity, why did V I return to resting levels soon after termination of hypoxia? Indeed, this is not the first investigation to show this disconnect between respiratory and sympathetic systems (21, 44) . Although data from the present study cannot directly address this question, the uncoupling between respiratory and sympathetic responses may lie in the central integration of afferent nerve signals. Hypoxic stimulation of the CC produces afferent signals to the rostral VLM via the nucleus of the solitary tract (NTS). Respiratory synchronization of the rostral VLM neurons suggests mediation by the central respiratory rhythm generator. However, in anesthetized cats, CC stimulation excited certain neurons in the NTS, which sent axonal projections directly to the rostral VLM (18) . The direct projections from the NTS to the rostral VLM may provide CC input to presympathetic cells, which is respiratory-independent (18) . Input from these neurons may explain the quick return of respiration to baseline values once hypoxia was terminated while sympathoexcitation continued (18, 19) .
The MAP response to hypoxia is a multifaceted process, including influence from the CC (13, 20) . In our subjects, the variable response of MAP to hypoxia is consistent with data from other investigations (16, 40) . Although the CC can at least partly mediate MAP during hypoxia, the vascular response is selective and can depend on the vascular bed under investigation (5, 13) . Additionally, hypoxia produces local vasodilation, which may counteract the hypoxia-induced sympathoexcitation (13, 31) . In the present study, when the hypoxic stimulus, and likely any local vasodilatory substances, was removed, MAP was not changed from baseline. Evidence from animals (9, 22) and humans (1, 12) demonstrates that long-term hypoxia, possibly in an intermittent fashion, is a requirement for a hypertensive effect that outlasts the hypoxic stimulus.
Methodological considerations. Hyperoxia is a safe, noninvasive intervention that attenuates CC activity (14, 28, 42) . Other investigations utilized dopamine infusion to "turn off" input from the CC (43). We chose hyperoxia over pharmacological blockade for two main reasons. 1) Although dopamine infusion inhibits chemoreceptor discharge, there is an accompanying alteration in other cardiorespiratory measures. Specifically, dopamine causes a dose-dependent increase or decrease in V I, a decrease in arterial PO 2 , and an increase in arterial PCO 2 , which would have had a direct neurostimulatory effect (43) . 2) To characterize the MSNA response to CC inhibition, we performed repeated hyperoxia trials. Repeated infusion of dopamine over the time course of the present study design would have had a variable effect on CC discharge: from inhibitory to excitatory (45) .
We used the microneurography technique to obtain a measure of sympathetic outflow. Although discharge of the peroneal nerve is similar to that demonstrated in the arm (29) and is correlated to norepinephrine spillover in other vascular beds (41), we cannot directly presume that our findings apply to other organs. The microneurography technique is particularly sensitive to movement, and any change in electrode position would have confounded our results. We minimized this possi- bility by immobilizing the leg throughout the experiment and excluding any data with a shift in the baseline signal of the mean voltage neurogram. Conclusion. We demonstrate an inhibitory effect of hyperoxia on elevated vasomotor outflow after exposure to isocapnic hypoxia. Our data, in conjunction with previous studies, suggest that hypoxia modulates the chemoreflex, in that there is sensitization of the peripheral chemoreceptors. This implies that continued elevated afferent signals from the CC are required in the persistent sympathoexcitation following exposure to hypoxia. These data provide a further explanation for the chronic daytime sympathoexcitation in patients with obstructive sleep apnea, which may contribute to the elevated incidence of cardiovascular disease in this population.
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